Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung

NCT03589547 is registered in ClinicalTrials.gov with Brown University as lead sponsor.

NCT NCT03589547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03589547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung
Lead sponsor
Brown University
Phase
Phase 2
Overall status
Completed
Start date
May 13, 2019
Completion date
February 18, 2026
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii non-small-cell lung cancer